Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionPlimoth Trust Co Llc
Latest Disclosed Ownership6,625 shares
Latest Disclosed Value $ 923,326
Plimoth Trust Co Llc ownership in GILD / Gilead Sciences, Inc.

On April 27, 2026 - Plimoth Trust Co Llc filed a 13F-HR form disclosing ownership of 6,625 shares of Gilead Sciences, Inc. (CH:GILD) valued at $923,326 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 27, 2026 disclosing 6,625 shares of Gilead Sciences, Inc.. This represents a change in shares of 0.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F Gilead Sciences Com 375558103 6,625 0 0.00 923 13.53 0.2064
2026-01-27 2025-12-31 13F Gilead Sciences Com 375558103 6,625 0 0.00 813 10.61 0.1812
2025-10-17 2025-09-30 13F Gilead Sciences Com 375558103 6,625 -370 -5.29 735 -5.16 0.1665
2025-07-22 2025-06-30 13F Gilead Sciences Com 375558103 6,995 0 0.00 776 -1.02 0.1860
2025-04-21 2025-03-31 13F Gilead Sciences Com 375558103 6,995 -170 -2.37 784 18.46 0.2042
2025-01-23 2024-12-31 13F Gilead Sciences Com 375558103 7,165 -200 -2.72 662 7.13 0.1700
2024-10-21 2024-09-30 13F Gilead Sciences Com 375558103 7,365 -50 -0.67 617 21.46 0.1556
2024-07-23 2024-06-30 13F Gilead Sciences Com 375558103 7,415 -370 -4.75 509 -10.88 0.1357
2024-04-18 2024-03-31 13F Gilead Sciences Com 375558103 7,785 -1,455 -15.75 570 -23.80 0.1519
2024-01-26 2023-12-31 13F Gilead Sciences Com 375558103 9,240 -10 -0.11 749 7.94 0.2160
2023-10-20 2023-09-30 13F Gilead Sciences Com 375558103 9,250 0 0.00 693 -2.67 0.2171
2023-07-24 2023-06-30 13F Gilead Sciences Com 375558103 9,250 -50 -0.54 713 -7.65 0.2133
2023-04-26 2023-03-31 13F Gilead Sciences Com 375558103 9,300 -175 -1.85 772 0.2394
2023-01-19 2022-12-31 13F Gilead Sciences Com 375558103 9,475 -235 -2.42 1 -100.00 0.2625
2022-10-18 2022-09-30 13F Gilead Sciences Com 375558103 9,710 -100 -1.02 600 -1.15 0.2074
2022-07-15 2022-06-30 13F Gilead Sciences Com 375558103 9,810 65 0.67 607 4.66 0.1915
2022-04-25 2022-03-31 13F Gilead Sciences Com 375558103 9,745 -360 -3.56 580 -20.98 0.1541
2022-01-27 2021-12-31 13F Gilead Sciences Com 375558103 10,105 -400 -3.81 734 0.00 0.1861
2021-10-22 2021-09-30 13F Gilead Sciences Com 375558103 10,505 -747 -6.64 734 -5.29 0.2075
2021-07-20 2021-06-30 13F Gilead Sciences Com 375558103 11,252 -3,555 -24.01 775 -19.02 0.2175
2021-04-14 2021-03-31 13F Gilead Sciences Com 375558103 14,807 -2,054 -12.18 957 -2.55 0.2824
2021-01-22 2020-12-31 13F Gilead Sciences Com 375558103 16,861 -5,260 -23.78 982 -29.76 0.3067
2020-10-27 2020-09-30 13F Gilead Sciences Com 375558103 22,121 -6,677 -23.19 1,398 -36.91 0.4688
2020-07-20 2020-06-30 13F Gilead Sciences Com 375558103 28,798 -2,199 -7.09 2,216 -4.36 0.7881
2020-04-22 2020-03-31 13F Gilead Sciences Com 375558103 30,997 -957 -2.99 2,317 11.61 0.9716
2020-01-29 2019-12-31 13F Gilead Sciences Com 375558103 31,954 -1,058 -3.20 2,076 -0.76 0.6714
2019-10-28 2019-09-30 13F Gilead Sciences Com 375558103 33,012 -9,349 -22.07 2,092 -26.90 0.6860
2019-08-05 2019-06-30 13F Gilead Sciences Com 375558103 42,361 -2,415 -5.39 2,862 -1.68 0.9418
2019-04-19 2019-03-31 13F Gilead Sciences Com 375558103 44,776 245 0.55 2,911 4.49 0.9683
2019-01-25 2018-12-31 13F Gilead Sciences Com 375558103 44,531 675 1.54 2,786 -17.72 1.0273
2018-12-13 2018-09-30 13F Gilead Sciences Com 375558103 43,856 365 0.84 3,386 9.90 1.0973
2018-12-12 2018-06-30 13F Gilead Sciences Com 375558103 43,491 2,455 5.98 3,081 -0.42 1.0558
2018-12-21 2018-03-31 13F Gilead Sciences Com 375558103 41,036 2,914 7.64 3,094 13.29 1.0688
2018-12-26 2017-12-31 13F Gilead Sciences Com 375558103 38,122 38,122 2,731 0.9782
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.